Noboru Taniguchi, M.D., Ph.D.

Noboru Taniguchi, M.D., Ph.D.


Osteoarthritis: Targeting a Protein in Cartilage Damage

Noboru Taniguchi, M.D., Ph.D.

The Scripps Research Institute
La Jolla, CA
A novel chromatin protein involved in cartilage homeostasis and osteoarthritis

Osteoarthritis is the most prevalent joint disease. In 1990 approximately 40 million Americans were affected and this number is predicted to increase to 60 million within the next twenty years as a result of population aging and an increase in life expectancy. Osteoarthritis begins with disruption of the cartilage surface and leads to progressive cartilage erosion, and aging is the major risk factor for this form of arthritis. However, mechanisms for the initiation of the earliest damage to cartilage are not known. Dr. Taniguchi focuses on the role of a novel chromatin protein in cartilage surface homeostasis and aging-dependent osteoarthritis. This information will not only be relevant to treating and possibly preventing osteoarthritis but also to cartilage tissue engineering.

Article Author
Arthritis National Research Foundation

The Arthritis National Research Foundation's mission is to provide initial research funding to brilliant, investigative scientists with new ideas to cure arthritis and related autoimmune diseases. Writing articles about the patients affected and the science being done to find a cure shows why we need to come together to #CureArthritis!

No Comments

Sorry, the comment form is closed at this time.